| 000 | 01363 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513122412.0 | ||
| 264 | 0 | _c19970917 | |
| 008 | 199709s 0 0 eng d | ||
| 022 | _a0169-328X | ||
| 024 | 7 |
_a10.1016/s0169-328x(97)00048-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHebb, M O | |
| 245 | 0 | 0 |
_aEnd-capped antisense oligodeoxynucleotides effectively inhibit gene expression in vivo and offer a low-toxicity alternative to fully modified phosphorothioate oligodeoxynucleotides. _h[electronic resource] |
| 260 |
_bBrain research. Molecular brain research _cJul 1997 |
||
| 300 |
_a223-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOligonucleotides _xpharmacology |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-fos _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aRobertson, H A | |
| 773 | 0 |
_tBrain research. Molecular brain research _gvol. 47 _gno. 1-2 _gp. 223-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0169-328x(97)00048-x _zAvailable from publisher's website |
| 999 |
_c9202184 _d9202184 |
||